US20090259263A1 - Apparatus and methods of fixating bone - Google Patents
Apparatus and methods of fixating bone Download PDFInfo
- Publication number
- US20090259263A1 US20090259263A1 US12/101,571 US10157108A US2009259263A1 US 20090259263 A1 US20090259263 A1 US 20090259263A1 US 10157108 A US10157108 A US 10157108A US 2009259263 A1 US2009259263 A1 US 2009259263A1
- Authority
- US
- United States
- Prior art keywords
- bones
- adhesive component
- bone
- scaffold material
- state
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 286
- 238000000034 method Methods 0.000 title claims abstract description 77
- 239000000463 material Substances 0.000 claims abstract description 180
- 239000000853 adhesive Substances 0.000 claims abstract description 130
- 230000001070 adhesive effect Effects 0.000 claims abstract description 130
- 210000001519 tissue Anatomy 0.000 claims abstract description 52
- 239000002131 composite material Substances 0.000 claims abstract description 47
- 230000007547 defect Effects 0.000 claims abstract description 36
- 238000002360 preparation method Methods 0.000 claims description 16
- 239000003999 initiator Substances 0.000 claims description 15
- 230000005855 radiation Effects 0.000 claims description 15
- 239000000560 biocompatible material Substances 0.000 claims description 13
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- 238000001356 surgical procedure Methods 0.000 claims description 11
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 8
- 208000006735 Periostitis Diseases 0.000 claims description 8
- 210000003460 periosteum Anatomy 0.000 claims description 8
- 229920001059 synthetic polymer Polymers 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 5
- 239000011800 void material Substances 0.000 claims description 5
- 238000007788 roughening Methods 0.000 claims description 4
- 210000004373 mandible Anatomy 0.000 claims description 3
- 230000000379 polymerizing effect Effects 0.000 claims 2
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002513 isocyanates Chemical class 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 238000007634 remodeling Methods 0.000 abstract description 3
- 229920000642 polymer Polymers 0.000 description 10
- 238000011282 treatment Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 4
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 4
- 230000008468 bone growth Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 210000000216 zygoma Anatomy 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000002639 bone cement Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 239000004824 Multi-part adhesive Substances 0.000 description 2
- 208000006670 Multiple fractures Diseases 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- -1 poly(lactic acid) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000009283 Craniosynostoses Diseases 0.000 description 1
- 206010049889 Craniosynostosis Diseases 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000002454 frontal bone Anatomy 0.000 description 1
- 210000001214 frontal sinus Anatomy 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000103 occipital bone Anatomy 0.000 description 1
- 210000003455 parietal bone Anatomy 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000002474 sphenoid bone Anatomy 0.000 description 1
- 210000003582 temporal bone Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2846—Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/688—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin for reattaching pieces of the skull
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00951—Material properties adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2875—Skull or cranium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30448—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
Definitions
- the present technology relates to apparatus and methods of treating or repairing hard tissue defects.
- a hard tissue defect such as fractured or misshapen bone
- More effective apparatus and methods are desired to enable such treatment, and to promote and enhance tissue repair in terms of clinical ease of use, cost, healing and efficacy.
- the present technology provides a method of fixating bone comprising connecting at least two bones and a scaffold material with an adhesive component such that the adhesive component is in contact with at least a portion of a surface of each of the bones and the scaffold material.
- the method further includes fixating the bones and the scaffold material to define a desired structure having a desired rigidity based on changing a material state of the adhesive component.
- a method of craniomaxillofacial surgery comprises accessing at least two bones at least partially defining a hard tissue defect at a location within a body, wherein the location comprises a cranial location or a maxillofacial location.
- the method further includes positioning the bones into a desired relative orientation, conforming a scaffold material to at least a portion of a surface of each of the bones, and contacting an adhesive component between at least a portion of each of the bones and the scaffold material.
- the method includes fixating the bones and the scaffold material in the desired relative orientation to remodel the hard tissue defect. The fixating is based on changing the adhesive component to a material state at which the adhesive component fastens together the bones and the scaffold material with a desired rigidity.
- a composite bone structure comprises a first bone having a first surface and at least one other bone, wherein each other bone comprises a respective second surface.
- the composite bone structure also includes a scaffold material positioned to connect the first bone and the at least one other bone, wherein the scaffold material is adaptable to conform to the first surface and each respective second surface.
- the composite bone structure includes an adhesive component in contact with at least a portion of the first bone, each other bone and the scaffold material, wherein the adhesive component is changeable to a material state at which the adhesive component affixes the first bone, each other bone and the scaffold material to define a composite bone structure having a desired rigidity.
- FIG. 1 is a perspective view of representative sites of hard tissue defects subject to treatment or repair according to the technology described herein;
- FIG. 2 is a diagrammatic representation of one aspect of a representative method of fixating bone to treat the hard tissue defect of FIG. 1 ;
- FIG. 3 is an exploded, cross-sectional view of one aspect of representative components of a composite bone implant
- FIG. 4 is a cross-sectional view of the composite bone implant of FIG. 3 forming a desired structure
- FIG. 5 is a cross-sectional view of the composite bone implant of FIG. 3 in a final state
- FIG. 6 is a transverse cross-sectional view of another aspect of a composite bone structure.
- FIG. 7 is a cross-sectional view of the composite bone structure in plane 7 - 7 of FIG. 6 .
- the described apparatus and methods of fixating bone relate to therapies or treatments for a hard tissue defect, which includes fractured or misshapen or deficient bone in a body of a patient.
- the hard tissue defect may be located anywhere on the body, and will be discussed specifically in relation to a maxillofacial defect 10 or a cranial defect 12 on a skull 14 of a patient.
- the apparatus and methods of fixating bone may include procedures such as, but not limited to: cranial or calvarial vault remodeling; maxillary complex fracture fixation procedures; comminuted bone procedures; cranial or neurosurgical flap procedures; craniosynostosis procedures; infant craniofacial surgery; pediatric reconstructive procedures; pediatric mid-face and craniofacial trauma procedures; brow-lift procedures; bone-graft procedures in the mid-face, mandible or craniofacial skeleton; trauma and reconstructive procedures of the mid-face or craniofacial skeleton, including frontal, parietal, temporal, sphenoid and occipital bones; fixation of fractures of the maxilla, zygoma, zygomatic arch, orbital rim, frontal sinus wall, nasal, ethmoid and lacrimal bones; iliac crest graft cover; mandibular osteotomies; tumor reconstruction in the mid-face or craniofacial procedures; Lefort
- a method of fixating bone to provide therapy for or treatment of a hard tissue defect includes obtaining two or more bones (Block 19 ).
- the bones may be obtained from the site of the hard tissue defect, as the treatment or therapy may involve remodeling the defect into a desired structure.
- the method may include preparing at least a portion of a surface of each of the bones (Block 21 ). The surface preparation is provided to enhance an ability of the bone to be fixated.
- the method involves positioning the bones for fixation (Block 23 ) in a desired relative orientation to achieve a desired remodeled structure.
- the method includes conforming a scaffold material, as defined below, to at least a portion of the surface of each of the bones (Block 25 ).
- the scaffold material may be positioned in contact with the respective prepared surfaces.
- the method includes contacting an adhesive component with and between each of the bones and the scaffold material (Block 27 ).
- the adhesive component or a portion of the adhesive component may be carried by the scaffold material, or may be added to the construct, or both.
- the method may include adding additional therapeutic or structural materials, or both, to the structure (Block 29 ).
- bone growth-promoting materials may be added to promote bone fusion, or bone void fillers such as bone cement or bone-growth scaffold may be added to fill in gaps between the bones.
- the method includes fixating the bones and the scaffold material (Block 31 ) to form a composite hard tissue or bone structure that defines at least a portion of the desired remodeled structure.
- the fixating includes changing a state of at least the adhesive component, and optionally of the scaffold material, to secure the bones and the scaffold material in the desired relative orientation.
- the at least two bones 30 and 32 may be obtained from a surgical site or location, such as the site of hard tissue defect 10 or 12 ( FIG. 1 ).
- more than two bones 30 , 32 and 33 may include bones associated with a hard tissue defect 11 , such as a fracture or multiple fractures in a long bone, in a zygomatic arch, or in any other skeletal structure.
- obtaining bones 30 and 32 may include obtaining one or more bone segments from other bodily locations, obtaining one or more allograft bone segments, or any combination thereof.
- the described aspects are not limited thereto, but may include any number of bone segments.
- the two or more bones 30 and 32 may include at least one portion of bone connected to a skeletal structure, or at least one separate bone segment, or both.
- the at least two bones 30 and 32 include hard tissue, which as noted above comprises bone, skeletal and/or ossified tissue.
- the at least two bones 30 and 32 may be fractured portions of bone, such as may result from local trauma. In other aspects, for example, the at least two bones 30 and 32 may be deformed portions of bone.
- the term “bone” may include a bone, any part or segment of a bone, or any fragment of a bone.
- obtaining the at least two bones 30 and 32 may further include a surgical procedure including accessing a harvesting location in the body of the patient.
- the surgical procedure may include making an incision through the skin and other soft tissue of the patient at the harvesting location to expose one or more of the at least two bones 30 or 32 .
- obtaining the at least two bones 30 or 32 may include removing fractured portions of bone from the accessed location, repositioning fractured portions of bone within the accessed location, cutting the bone at the accessed location to define one or more of the at least two bones 30 or 32 , or a combination of both.
- obtaining the at least two bones 30 or 32 may further include obtaining one or more allograft bone segments.
- the method optionally includes applying a surface preparation to at least a portion of a surface of the bones 30 and 32 (and, optionally, 33 ) (Block 21 ).
- a surface preparation to at least a portion of a surface of the bones 30 and 32 (and, optionally, 33 ) (Block 21 ).
- the surface preparation may be applied at any time before, during or after the positioning. Referring to FIGS.
- the surface preparation may include any surface treatment effective to increase an ability of adhesive component 34 to secure scaffolding material 36 or 37 to the respective bones 30 and 32 (and 33 ), to improve fusion with an adjacent bone segment, to shape the respective bones 30 or 32 (or 33 ) into a desired form, or any combination thereof It should be noted that the surface treatment may be applied to any surface used to connect together one or more bones or a bone and the scaffold material.
- the surface preparation may be applied to at least a respective portion, such as portions 38 and 40 , of a respective external or top surface 42 and 44 of the respective bones 30 and 32 .
- a respective portion 38 and 40 substantially corresponds to an area in which scaffolding material 36 will be placed.
- the surface preparation may include roughening the top or external-facing surface 42 and 44 .
- the top or external-facing surface 42 and 44 faces away from the body of the patient, and opposed to a respective bottom or internal-facing surface 46 and 48 .
- such surface roughening may comprise mechanically abrading the respective bone surfaces, such as with a surgical tool having an abrading element, or may comprise removal of a portion of the surface, such as with a surgical tool having a cutting element.
- the surface preparation may be applied to respective side surfaces 52 and 54 , defined between each respective top or external-facing surface 42 and 44 and each respective bottom or internal-facing surface 46 and 48 , to improve an ability of the respective side surfaces 52 and 54 to fuse to one another or alter the bonding interface with the adhesive component 34 .
- the surface preparation may include temporarily or permanently removing or peeling back a periosteum layer 50 from the respective portions 38 and 40 of the respective top or external-facing surfaces 42 and 44 of the bones 30 and 32 . Further, the surface preparation may include reshaping one or more of bones 30 and 32 to obtain a desired remodeled structure to treat hard tissue defect 10 or 12 . Alternatively, or in addition, the surface preparation may further include drying the respective portions 38 and 40 of the surfaces of bones 30 and 32 to enable improved contact with scaffold material 36 and/or adhesive component 34 .
- the surface preparation may include applying a chemical to perform one or more actions, such as removing the periosteum layer 50 , roughening at least a portion of respective surfaces of bones 30 and 32 , reforming the shape of one or more bones 30 and 32 , drying the surface, removing a selected material from the surface, such as a lipid, or any combination thereof.
- a chemical to perform one or more actions such as removing the periosteum layer 50 , roughening at least a portion of respective surfaces of bones 30 and 32 , reforming the shape of one or more bones 30 and 32 , drying the surface, removing a selected material from the surface, such as a lipid, or any combination thereof.
- the bones 30 and 32 are placed in a desired relative position (Block 23 ).
- the relative positioning of the bones is shown in FIG. 2 and discussed herein as occurring prior to the conforming of the scaffold material (Block 25 ) and the contacting of the adhesive component (Block 27 ), the relative positioning may occur once or may occur multiple times before or after other steps of the described methods.
- respective side surfaces 52 and 54 are positioned opposing one another and are moved into a desired orientation adjacent to one another.
- the at least two bones 30 and 32 are moved toward one another until a desired orientation ( FIG.
- the desired orientation may include a position wherein at least portions, and preferably a majority, of respective side surfaces 52 and 54 are contiguous or are in contact with one another so as to enable bone growth between the respective side surfaces 52 and 54 .
- gaps may exist or may be desirable between the at least two bones 30 and 32 .
- such gaps may be filled with a bone void filler, such as a bone cement or a bone-growth scaffold.
- the desired orientation may include the respective top surfaces 42 and 44 having a desired form, such as an arc, a plane, an orientation, or a combination thereof.
- the desired orientation may correspond to a desired remodeled structure to treat hard tissue defect 10 or 12 .
- the positioning of the at least two bones 30 and 32 may include positioning in situ, in vitro, or a combination thereof.
- the desired orientation may remodel the long bone, zygomatic arch, or multiple fracture defect into a shape that approximates a non-defective skeletal structure.
- the positioning of bones 30 and 32 may include positioning against a mold 64 having a mold surface 66 with a desired shape.
- the desired shape corresponds to a desired orientation of bones 30 and 32 , or a desired remodeled structure to treat hard tissue defect 10 or 12 .
- the optional positioning against mold 64 may alternatively include positioning top or external-facing surfaces 42 and 44 against mold surface 66 .
- the method further includes conforming the scaffold material, which in some optional aspects may include the adhesive component, to at least a portion of the surface of each of the bones (Block 25 ).
- scaffold material 36 is moved in direction 59 and placed across an interface or gap 68 ( FIG. 4 ) between the opposing side surfaces 52 and 54 of bones 30 and 32 .
- at least a part of scaffold material 36 is placed into contact with the opposing prepared surface portions 38 and 40 of bones 30 and 32 , thereby bridging interface 68 .
- interface 68 may comprise any shape or combination of shapes.
- scaffold material 36 is positioned such that at least a portion of adhesive component 34 connects between scaffold material 36 and the opposing prepared surface portions 38 and 40 of bones 30 and 32 .
- scaffold material 36 which may include or carry adhesive component 34 , is positioned in a manner to allow for securing bones 30 and 32 (and, optionally, 33 in FIG. 7 ) in a desired relative orientation, and to further bridge interface 68 (or defect 11 in FIG. 7 ) to promote bony fusion between the adjacent bone segments.
- scaffold material 37 may be wrapped around hard tissue defect 11 , thereby fully enveloping the defective skeletal structure.
- the wrapping of the scaffold material 37 and subsequent fixation provides support to the structure in multiple directions.
- Scaffold material 36 (or 37 ) may comprise any material capable of carrying adhesive component 34 .
- scaffold material 36 (or 37 ) may include, but is not limited to, materials such as a woven fabric, a mesh, a foam, a plate, a perforated membrane, a sheet, a porous structure, a PolyLactide weave or any combination thereof.
- scaffold material 36 (or 37 ) may have a surface that includes voids, peaks and valleys, ridges, grooves, channels, any combination thereof, or any other irregular surface that improves an ability of adhesive component 34 to bond or interdigitate with scaffold material 36 (or 37 ).
- scaffold material 36 may be pre-impregnated with a desired or an effective amount of adhesive component 34 , or all or some portion of the desired or effective amount of adhesive component 34 may be added to scaffold material 36 (or 37 ) at any time during the procedure described herein.
- the desired or effective amount of adhesive component may comprise an amount effective to enable binding between scaffold material 36 (or 37 ) and at least respective portions 38 and 40 of respective bones 30 and 32 , or to provide a desired rigidity or stiffness to the resulting structure, or both.
- scaffold material 36 (or 37 ) may be sized so that the combination of bone segments 30 and 32 and scaffold material 36 (or 37 ) define a desired remodeled structure.
- scaffold material 36 (or 37 ) comprises a biocompatible material.
- scaffold material 36 (or 37 ) further comprises a bioresorbable material.
- scaffold material 36 (or 37 ) may comprise a polymer, a resorbable polymer, a urethane, a polyeurethane, a metal, a biocompatible material, a calcium salt material, a tissue, collagen, cellulose or combinations thereof
- scaffold material 36 (or 37 ) may comprise a LACTOSORB plate available from Biomet, Inc. of Warsaw, Ind.
- the method further includes contacting the adhesive component between the bones and the scaffold material (Block 27 ).
- adhesive component 34 may be carried by scaffold material 36 or 37 , or may be separately added, or both.
- scaffold material 36 or 37 includes adhesive component 34 on a surface facing the bones 30 and 32 (and, optionally, 33 ), thereby connecting the bones and the scaffold material when the scaffold material is adapted to conform to at least a portion of the respective surfaces of the bones.
- adhesive component 34 may comprise any material capable of forming a bond between scaffold material 36 or 37 and bones 30 and 32 (and, optionally, 33 ), whether by chemical bonding, interdigitation or another method or combination of methods used to form a mechanical bond between the scaffold material and bone segments. Further, adhesive component 34 comprises a biocompatible material. In some aspects, adhesive component 34 further comprises a bioresorbable material.
- adhesive component 34 may comprise a material such as a polymer, a urethane, a polyeurethane, an amino acid containing polymer, an acrylic, a cyanoacrylate, a polymethyl methacrylate (PMMA), an alkylene bis(oligolactoyl)methacrylate, a fibrin-based material, a bone welding material, or combinations thereof.
- a material such as a polymer, a urethane, a polyeurethane, an amino acid containing polymer, an acrylic, a cyanoacrylate, a polymethyl methacrylate (PMMA), an alkylene bis(oligolactoyl)methacrylate, a fibrin-based material, a bone welding material, or combinations thereof.
- adhesive component 34 may comprise a synthetic polymer, such as a biodegradable, polyester urethane/urea composition.
- adhesive component 34 may comprise a combination of pre-polymers operable to react to form a cross-linked polymer network.
- the combination of pre-polymers may include a first pre-polymer having isocyanate groups, such as from the combination of lysine di-isocyante and pentaerythritol, and a second pre-polymer comprising a multi-branched polyol, such as poly(lactic acid)polyol (PLA), polyglycolic acid (PGA), caprolactone, etc.
- the biodegradable, polyester urethane/urea composition may comprise one of the NOVOSORB materials available from PolyNovo Biomaterials Pty. Ltd. of Australia.
- adhesive component 34 comprises a plurality of states, including an initial unpolymerized or minimally polymerized state prior to and upon positioning of scaffolding material 36 (or 37 ) and bones 30 and 32 (and 33 ), then a fully polymerized or cured state after such positioning, for example, after exposure to an initiator 69 such as an additional chemical component, a light or radiation wave, etc., as will be discussed below in more detail.
- an initiator 69 such as an additional chemical component, a light or radiation wave, etc.
- scaffold material 36 (or 37 ) and adhesive component 34 may be formed from substantially the same material.
- scaffold material 36 (or 37 ) and adhesive component 34 may be formed from materials having substantially the same rate of resorption, which may provide a therapeutic benefit with respect to uniform degradation of the fixated structure, avoiding inflammation, or providing improved healing.
- the method may optionally include adding additional therapeutic or structural materials, or both, to the structure (Block 29 ).
- bone growth-promoting materials may be added to promote bone fusion.
- void fillers such as bone cement or bone-growth scaffold may be added to fill gaps between the bones.
- other therapeutic agents such as gene therapy agents, infection-avoidance agents, pain-relieving agents, etc., may be added.
- fixating bones 30 and 32 is based on changing at least adhesive component 34 from a first material state to a second material state.
- adhesive component 34 may comprise a relatively flexible state.
- the first material state may be a liquid state, a semi-solid state, or a non-rigid solid state.
- the first material state has a viscosity sufficient to enable adhesive component 34 to be controllably positioned.
- adhesive component 34 may be controllably positioned by having a viscosity and adhesion characteristic that allows adhesive component 34 to be controllably maintained on a desired surface, such as on a respective bone surface or on scaffold material, or both, to allow a user to avoid contacting the adhesive component with non-desired contact areas, such as areas within a surgical site other than the prepared surfaces of the bones or other than within scaffold material, or both.
- adhesive component 34 comprises sufficient flexibility to enable contact with bones and scaffold material.
- adhesive component 34 is operable to bind to scaffold material 36 as well as to two or more bones 30 and 32 (or 30 , 32 and 33 ). Further, at the second material state, adhesive component 34 forms a structure having a desired rigidity or stiffness.
- the desired rigidity or stiffness may include, but is not limited to, a range of rigidities or stiffnesses substantially corresponding to the range of rigidities of hard tissue, such as the particular hard tissue comprising one or more of bones 30 and 32 (or 30 , 32 and 33 ).
- adhesive component 34 comprises sufficient rigidity or stiffness to resist movement of the bones and scaffold material from the desired shape or orientation.
- adhesive component 34 which may be carried by scaffolding material 36 or 37 , changes into a state to secure scaffold material 36 (or 37 ) and two or more bones 30 and 32 (or 30 , 32 and 33 ) at a desired orientation, thereby forming a composite bone structure 70 ( FIG. 5 ) or 71 ( FIG. 7 ) having a desired shape or form to treat or remodel hard tissue defect 10 or 12 ( FIG. 1 ) or 11 ( FIG. 7 ).
- the fixating may further include changing the state of scaffold material 36 (or 37 ) from a first state having substantial flexibility to a second state having substantial rigidity or stiffness.
- the substantial flexibility comprises an amount of flexibility that allows scaffold material 36 or 37 to conform to a surface of the two or more bones 30 and 32 (or 30 , 32 and 33 ).
- the substantial rigidity may include an amount of rigidity or stiffness at the second state greater than the amount that existed at the first state, which may include an amount of rigidity or stiffness to resist movement of the bones and the scaffold material out of the desired shape or form.
- the changing of states of adhesive component 34 involves application of an initiator 69 operable to change at least adhesive component 34 to a second polymer state different from a first polymer state, wherein the second polymer state comprises a cured state or a partially-cured or partial polymerization state.
- an initiator 69 operable to change at least adhesive component 34 to a second polymer state different from a first polymer state, wherein the second polymer state comprises a cured state or a partially-cured or partial polymerization state.
- the partial polymerization state is some state achieving less than substantially all of the mechanical strength of the adhesive, where mechanical strength may include one or more of bonding strength, rigidity, or stiffness.
- the method may include changing from the second state of partial polymerization to a third state of substantially full polymerization or full cure, thereby securing the relative orientation of composite bone structure 70 or 71 .
- Initiator 69 may include, but is not limited to, a radiation-based initiator, of which a light based initiator would be one example, a temperature change-based initiator, a chemical-based initiator, or any combination thereof or any combination of different types of each one.
- adhesive component 34 may comprise a multi-part adhesive having at least two parts, wherein combination of a second part with the first part initiates a chemical reaction operable to change adhesive component 34 from the first relatively flexible state to the second relatively rigid state.
- a multi-part adhesive component 34 includes, but is not limited to, a biodegradable, polyester urethane/urea composition such as one of the NOVOSORB materials available from PolyNovo Biomaterials Pty. Ltd. of Australia.
- the radiation-based, or more specifically the light-based, initiator may comprise exposure to one or more light waves or radiation waves having a desired wavelength or range/band or ranges/bands of desired wavelengths to effect curing of the adhesive component.
- the initiator 69 may comprise ambient light, which includes as a component light of the wavelength of interest and which may slowly cure the adhesive component.
- a light of greater intensity and, specifically, with a greater intensity at a specific wavelength or band of wavelengths may be used to accelerate the light based curing process.
- the application of initiator 69 may differ throughout the fixation process, such as in the case where a partial fixation is achieved prior to a final fixation.
- the method of causing polymerization up to a partial polymerization state may further include exposing adhesive component 34 to a first radiation at a first set of one or more wavelengths for a first time period operable to achieve less than substantially all of the mechanical strength of adhesive component.
- the first radiation has a source including a laser or other directed source that generates locally-focused radiation waves directed substantially on adhesive material 34 .
- changing adhesive component 34 to the substantially fully polymerized state may include additionally exposing adhesive component 34 to the first radiation for a second time period.
- changing the adhesive component to the substantially fully polymerized state may include additionally exposing the adhesive component to a second radiation for a second time period and/or at a second set of one or more wavelengths different from the first set of one or more wavelengths.
- the second radiation may have a source including a different type of laser or other directed light source, or may include an ambient radiation source operable to generate non-locally-focused light waves, i.e. radiation or light waves not directed primarily on the adhesive component or the scaffold material.
- adhesive component 34 (and/or scaffold material 36 or 37 ) may have a different perceived color at each material state.
- adhesive component 34 may provide a perceptible visual indicator corresponding to the respective material state, thereby aiding a surgeon or other party in ascertaining the material state.
- composite bone structure 70 or 71 has been discussed in terms of bones 30 and 32 or 30 , 32 and 33 , any number of bones may be utilized. Similarly, one or more composite bone structures 70 or 71 may be joined together, or composite bone structure 70 or 71 and non-harvested bone, such as adjacent to the site of hard tissue defect 10 , 11 or 12 , may be joined together in a similar manner as described above for joining two or more bones 30 and 32 , or 30 , 32 and 33 .
- the method of joining composite bone structure to another bone may include positioning the composite bone structure adjacent to at least one other bone at the implant site. Further, the method may include positioning a second scaffold material including a second adhesive component across at least a portion of each of the composite bone structure and the at least one other bone such that the second adhesive component is in contact with both the composite bone structure and the at least one other bone.
- the second scaffold material and the second adhesive component both comprise a material state being substantially flexible.
- this method includes fixating the composite bone structure and the at least one other bone based on changing at least the second adhesive component to another material state at which the second adhesive component chemically or mechanically binds to the second scaffold material, the composite bone structure and the at least one other bone, thereby forming a structure having a desired rigidity, as described above.
- FIGS. 4 and 5 include bone segments 30 and 32 having periosteum 50
- one or both of bone segments 30 and 32 may be obtained without periosteum 50 , such as in the case of one or both segments 30 and 32 comprising allograft bone or as in the case where the periosteum is removed from the patient's own bone intraoperatively.
- the method of FIG. 2 may be utilized specifically for craniomaxillofacial surgery.
- the method of craniomaxillofacial surgery includes accessing at least two bones at least partially defining a hard tissue defect at a location within a body, wherein the location comprises a cranial location or a maxillofacial location or mandible.
- at least one of the bones may be obtained from the defect location, while one or more of the other bones may be obtained from another harvesting location on the body, or may be obtained as an allograft.
- the bones may be obtained from the hard tissue location.
- At least one of the bones may be a portion of cranial or maxillofacial bone at or adjacent to the hard tissue defect location and connected to or integral with the skull.
- the hard tissue defect location comprises one of a cranial location or a maxillofacial location.
- the method of craniomaxillofacial surgery includes positioning the bones into a desired relative orientation.
- the bones are positioned such that opposing surfaces of the respective bone segments are facing one another, thereby defining an interface between the bone segments.
- the method of craniomaxillofacial surgery includes conforming a scaffold material to at least a portion of a surface of each of the bones. Further, the method includes contacting an adhesive component between at least a portion of each of the bones and the scaffold material.
- the scaffold material spans the interface between the bones, thereby allowing the adhesive component to define a connection between the bones and the scaffold material.
- the scaffold material and the adhesive component both comprise a first material state being substantially flexible to allow such contact.
- the method of craniomaxillofacial surgery includes fixating the bones and the scaffold material in the desired relative orientation to remodel the hard tissue defect.
- the fixating is based on changing at least the adhesive component to a second material state at which the adhesive component mechanically or chemically binds the bones and the scaffold material, thereby forming a composite bone structure having a desired rigidity.
- the fixating may involve both the adhesive component and the scaffold material changing into the second material state to define the relatively rigid structure used to repair the hard tissue defect.
- a composite bone structure 70 ( FIG. 5 ) or 71 ( FIG. 7 ) that includes hard tissues/bones 30 and 32 , or 30 , 32 and 33 , joined together by an adhesive component 34 carried by a scaffold material 36 or 37 .
- hard tissue/bone 30 has a first surface 52
- hard tissue/bone 32 has a second surface 54
- bones 30 and 32 are relatively positioned so as to define an interface 68 between at least a portion of the respective surfaces 52 and 54 .
- scaffold material 36 is positioned adjacent to at least a portion of the hard tissues/bones 30 and 32 , such that scaffold material 36 spans at least a portion of interface 68 .
- adhesive component 34 is in contact with at least a portion of each of the hard tissues/bones 30 and 32 and scaffold material 36 .
- Scaffold material 36 and adhesive component 34 both initially comprise a first material state being substantially flexible to enable their positioning relative to the respective hard tissues/bones 30 and 32 .
- at least adhesive component 34 is changeable to a second material state at which adhesive component 34 binds to each of the hard tissues/bones 30 and 32 and scaffold material 36 , thereby defining composite bone structure 70 having a desired rigidity.
- scaffold material 37 wraps around hard tissues/bones 30 , 32 and 33 , and adhesive component 34 affixes the hard tissues/bones 30 , 32 and 33 and scaffold material 37 in a desired orientation and further defines composite bone structure 71 having a desired rigidity.
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- The present technology relates to apparatus and methods of treating or repairing hard tissue defects.
- The treatment of a hard tissue defect, such as fractured or misshapen bone, involves a number of complex surgical procedures. More effective apparatus and methods are desired to enable such treatment, and to promote and enhance tissue repair in terms of clinical ease of use, cost, healing and efficacy.
- In some aspects, the present technology provides a method of fixating bone comprising connecting at least two bones and a scaffold material with an adhesive component such that the adhesive component is in contact with at least a portion of a surface of each of the bones and the scaffold material. The method further includes fixating the bones and the scaffold material to define a desired structure having a desired rigidity based on changing a material state of the adhesive component.
- In another aspect, a method of craniomaxillofacial surgery comprises accessing at least two bones at least partially defining a hard tissue defect at a location within a body, wherein the location comprises a cranial location or a maxillofacial location. The method further includes positioning the bones into a desired relative orientation, conforming a scaffold material to at least a portion of a surface of each of the bones, and contacting an adhesive component between at least a portion of each of the bones and the scaffold material. Additionally, the method includes fixating the bones and the scaffold material in the desired relative orientation to remodel the hard tissue defect. The fixating is based on changing the adhesive component to a material state at which the adhesive component fastens together the bones and the scaffold material with a desired rigidity.
- In a further aspect, a composite bone structure comprises a first bone having a first surface and at least one other bone, wherein each other bone comprises a respective second surface. The composite bone structure also includes a scaffold material positioned to connect the first bone and the at least one other bone, wherein the scaffold material is adaptable to conform to the first surface and each respective second surface. Additionally, the composite bone structure includes an adhesive component in contact with at least a portion of the first bone, each other bone and the scaffold material, wherein the adhesive component is changeable to a material state at which the adhesive component affixes the first bone, each other bone and the scaffold material to define a composite bone structure having a desired rigidity.
- Further areas of applicability of the present teachings will become apparent from the detailed description provided herein. It should be understood that the detailed description and specific examples, while indicating various embodiments of the technology described below, are intended for purposes of illustration only and are not intended to limit the scope of the teachings.
- The present teachings will become more fully understood from the detailed description and the accompanying drawings, wherein:
-
FIG. 1 is a perspective view of representative sites of hard tissue defects subject to treatment or repair according to the technology described herein; -
FIG. 2 is a diagrammatic representation of one aspect of a representative method of fixating bone to treat the hard tissue defect ofFIG. 1 ; -
FIG. 3 is an exploded, cross-sectional view of one aspect of representative components of a composite bone implant; -
FIG. 4 is a cross-sectional view of the composite bone implant ofFIG. 3 forming a desired structure; -
FIG. 5 is a cross-sectional view of the composite bone implant ofFIG. 3 in a final state; -
FIG. 6 is a transverse cross-sectional view of another aspect of a composite bone structure; and -
FIG. 7 is a cross-sectional view of the composite bone structure in plane 7-7 ofFIG. 6 . - The following description of technology is merely exemplary of the subject matter, manufacture and use of one or more inventions, and is not intended to limit the scope, application, or uses of any specific invention claimed in this application or in such other applications as may be filed claiming priority to this application, or patents issuing therefrom.
- Referring to
FIG. 1 , the described apparatus and methods of fixating bone relate to therapies or treatments for a hard tissue defect, which includes fractured or misshapen or deficient bone in a body of a patient. The hard tissue defect may be located anywhere on the body, and will be discussed specifically in relation to amaxillofacial defect 10 or acranial defect 12 on askull 14 of a patient. For example, the apparatus and methods of fixating bone may include procedures such as, but not limited to: cranial or calvarial vault remodeling; maxillary complex fracture fixation procedures; comminuted bone procedures; cranial or neurosurgical flap procedures; craniosynostosis procedures; infant craniofacial surgery; pediatric reconstructive procedures; pediatric mid-face and craniofacial trauma procedures; brow-lift procedures; bone-graft procedures in the mid-face, mandible or craniofacial skeleton; trauma and reconstructive procedures of the mid-face or craniofacial skeleton, including frontal, parietal, temporal, sphenoid and occipital bones; fixation of fractures of the maxilla, zygoma, zygomatic arch, orbital rim, frontal sinus wall, nasal, ethmoid and lacrimal bones; iliac crest graft cover; mandibular osteotomies; tumor reconstruction in the mid-face or craniofacial procedures; Lefort fractures (I,II,III); proximal tibia revisions; and generally any bone defect correction procedure. Additionally, as referred to herein, the term “hard tissue” relates to bone, skeletal or ossified tissue, which is relatively hard and rigid as compared to other bodily tissue such as skin. - Referring to
FIG. 2 , in one aspect, a method of fixating bone to provide therapy for or treatment of a hard tissue defect includes obtaining two or more bones (Block 19). For example, the bones may be obtained from the site of the hard tissue defect, as the treatment or therapy may involve remodeling the defect into a desired structure. Optionally, as indicated by dashed lines, the method may include preparing at least a portion of a surface of each of the bones (Block 21). The surface preparation is provided to enhance an ability of the bone to be fixated. The method involves positioning the bones for fixation (Block 23) in a desired relative orientation to achieve a desired remodeled structure. Further, the method includes conforming a scaffold material, as defined below, to at least a portion of the surface of each of the bones (Block 25). For example, the scaffold material may be positioned in contact with the respective prepared surfaces. Moreover, the method includes contacting an adhesive component with and between each of the bones and the scaffold material (Block 27). The adhesive component or a portion of the adhesive component may be carried by the scaffold material, or may be added to the construct, or both. Optionally, as indicated by dashed lines, the method may include adding additional therapeutic or structural materials, or both, to the structure (Block 29). For example, bone growth-promoting materials may be added to promote bone fusion, or bone void fillers such as bone cement or bone-growth scaffold may be added to fill in gaps between the bones. Additionally, the method includes fixating the bones and the scaffold material (Block 31) to form a composite hard tissue or bone structure that defines at least a portion of the desired remodeled structure. The fixating includes changing a state of at least the adhesive component, and optionally of the scaffold material, to secure the bones and the scaffold material in the desired relative orientation. Each of the aforementioned actions will be more fully discussed below. - As discussed above, at least two bones are obtained (Block 19). For example, in one aspect, referring to
FIGS. 1 and 3 , the at least twobones 30 and 32 (FIG. 3 ) may be obtained from a surgical site or location, such as the site ofhard tissue defect 10 or 12 (FIG. 1 ). Further, referring toFIGS. 6 and 7 , for example, more than twobones hard tissue defect 11, such as a fracture or multiple fractures in a long bone, in a zygomatic arch, or in any other skeletal structure. Although discussed as being obtained fromhard tissue defect aspects obtaining bones 30 and 32 (and/or 33) may include obtaining one or more bone segments from other bodily locations, obtaining one or more allograft bone segments, or any combination thereof. Further, although discussed in terms of the at least twobones more bones bones bones bones - Additionally, obtaining the at least two
bones bones bones bones bones - Referring again to
FIG. 2 , the method optionally includes applying a surface preparation to at least a portion of a surface of thebones 30 and 32 (and, optionally, 33) (Block 21). Although the surface preparation (Block 21) is shown inFIG. 2 and discussed herein as occurring prior to the positioning ofbones 30 and 32 (Block 23), the surface preparation may be applied at any time before, during or after the positioning. Referring toFIGS. 3 , 6 and 7, the surface preparation may include any surface treatment effective to increase an ability ofadhesive component 34 to securescaffolding material respective bones 30 and 32 (and 33), to improve fusion with an adjacent bone segment, to shape therespective bones 30 or 32 (or 33) into a desired form, or any combination thereof It should be noted that the surface treatment may be applied to any surface used to connect together one or more bones or a bone and the scaffold material. - Referring specifically to
FIG. 3 , in one aspect, the surface preparation may be applied to at least a respective portion, such asportions top surface respective bones respective portion scaffolding material 36 will be placed. The surface preparation may include roughening the top or external-facingsurface surface surface surface surface adhesive component 34. - Referring to
FIG. 4 , additionally or alternatively, in other aspects, the surface preparation may include temporarily or permanently removing or peeling back aperiosteum layer 50 from therespective portions surfaces bones bones hard tissue defect respective portions bones scaffold material 36 and/oradhesive component 34. In yet other aspects, the surface preparation may include applying a chemical to perform one or more actions, such as removing theperiosteum layer 50, roughening at least a portion of respective surfaces ofbones more bones - Referring again to
FIG. 2 , thebones 30 and 32 (and, optionally, 33) are placed in a desired relative position (Block 23). Although the relative positioning of the bones is shown inFIG. 2 and discussed herein as occurring prior to the conforming of the scaffold material (Block 25) and the contacting of the adhesive component (Block 27), the relative positioning may occur once or may occur multiple times before or after other steps of the described methods. In one aspect, for example referring toFIGS. 3 and 4 , respective side surfaces 52 and 54 are positioned opposing one another and are moved into a desired orientation adjacent to one another. In particular, as noted byarrows 56 and 58 (FIG. 3 ), the at least twobones FIG. 4 ) ofbones bones - Further, for example, the desired orientation (
FIG. 4 ) may include the respectivetop surfaces hard tissue defect bones FIG. 7 , the desired orientation may remodel the long bone, zygomatic arch, or multiple fracture defect into a shape that approximates a non-defective skeletal structure. - In an optional aspect, referring to
FIG. 3 , as indicated byarrows bones mold 64 having amold surface 66 with a desired shape. For example, the desired shape corresponds to a desired orientation ofbones hard tissue defect surfaces bones mold surface 66, it should be understood that the optional positioning againstmold 64 may alternatively include positioning top or external-facingsurfaces mold surface 66. - Referring back to
FIG. 2 , the method further includes conforming the scaffold material, which in some optional aspects may include the adhesive component, to at least a portion of the surface of each of the bones (Block 25). In one aspect, for example referring toFIGS. 3 and 4 ,scaffold material 36 is moved indirection 59 and placed across an interface or gap 68 (FIG. 4 ) between the opposing side surfaces 52 and 54 ofbones scaffold material 36 is placed into contact with the opposingprepared surface portions bones interface 68. Although illustrated as a plane, it should be noted thatinterface 68 may comprise any shape or combination of shapes. Further, for example,scaffold material 36 is positioned such that at least a portion ofadhesive component 34 connects betweenscaffold material 36 and the opposingprepared surface portions bones scaffold material 36, which may include or carryadhesive component 34, is positioned in a manner to allow for securingbones 30 and 32 (and, optionally, 33 inFIG. 7 ) in a desired relative orientation, and to further bridge interface 68 (ordefect 11 inFIG. 7 ) to promote bony fusion between the adjacent bone segments. - In another aspect, referring to
FIGS. 6 and 7 ,scaffold material 37 may be wrapped aroundhard tissue defect 11, thereby fully enveloping the defective skeletal structure. In this aspect, the wrapping of thescaffold material 37 and subsequent fixation provides support to the structure in multiple directions. - Scaffold material 36 (or 37) may comprise any material capable of carrying
adhesive component 34. For example, scaffold material 36 (or 37) may include, but is not limited to, materials such as a woven fabric, a mesh, a foam, a plate, a perforated membrane, a sheet, a porous structure, a PolyLactide weave or any combination thereof. Further, for example, scaffold material 36 (or 37) may have a surface that includes voids, peaks and valleys, ridges, grooves, channels, any combination thereof, or any other irregular surface that improves an ability ofadhesive component 34 to bond or interdigitate with scaffold material 36 (or 37). Further, for example, scaffold material 36 (or 37) may be pre-impregnated with a desired or an effective amount ofadhesive component 34, or all or some portion of the desired or effective amount ofadhesive component 34 may be added to scaffold material 36 (or 37) at any time during the procedure described herein. For example, the desired or effective amount of adhesive component may comprise an amount effective to enable binding between scaffold material 36 (or 37) and at leastrespective portions respective bones bone segments - Further, scaffold material 36 (or 37) comprises a biocompatible material. In some aspects, scaffold material 36 (or 37) further comprises a bioresorbable material. For example, scaffold material 36 (or 37) may comprise a polymer, a resorbable polymer, a urethane, a polyeurethane, a metal, a biocompatible material, a calcium salt material, a tissue, collagen, cellulose or combinations thereof In one example, which is not to be construed as limiting, scaffold material 36 (or 37) may comprise a LACTOSORB plate available from Biomet, Inc. of Warsaw, Ind.
- Contact the Adhesive with Bones And Scaffold
- Referring back to
FIG. 2 , the method further includes contacting the adhesive component between the bones and the scaffold material (Block 27). As previously noted,adhesive component 34 may be carried byscaffold material scaffold material adhesive component 34 on a surface facing thebones 30 and 32 (and, optionally, 33), thereby connecting the bones and the scaffold material when the scaffold material is adapted to conform to at least a portion of the respective surfaces of the bones. - Additionally,
adhesive component 34 may comprise any material capable of forming a bond betweenscaffold material bones 30 and 32 (and, optionally, 33), whether by chemical bonding, interdigitation or another method or combination of methods used to form a mechanical bond between the scaffold material and bone segments. Further,adhesive component 34 comprises a biocompatible material. In some aspects,adhesive component 34 further comprises a bioresorbable material. For example,adhesive component 34 may comprise a material such as a polymer, a urethane, a polyeurethane, an amino acid containing polymer, an acrylic, a cyanoacrylate, a polymethyl methacrylate (PMMA), an alkylene bis(oligolactoyl)methacrylate, a fibrin-based material, a bone welding material, or combinations thereof. - In one example, which is not to be construed as limiting,
adhesive component 34 may comprise a synthetic polymer, such as a biodegradable, polyester urethane/urea composition. For example,adhesive component 34 may comprise a combination of pre-polymers operable to react to form a cross-linked polymer network. For example, the combination of pre-polymers may include a first pre-polymer having isocyanate groups, such as from the combination of lysine di-isocyante and pentaerythritol, and a second pre-polymer comprising a multi-branched polyol, such as poly(lactic acid)polyol (PLA), polyglycolic acid (PGA), caprolactone, etc. For example, the biodegradable, polyester urethane/urea composition may comprise one of the NOVOSORB materials available from PolyNovo Biomaterials Pty. Ltd. of Australia. - Additionally, in some aspects,
adhesive component 34 comprises a plurality of states, including an initial unpolymerized or minimally polymerized state prior to and upon positioning of scaffolding material 36 (or 37) andbones 30 and 32 (and 33), then a fully polymerized or cured state after such positioning, for example, after exposure to aninitiator 69 such as an additional chemical component, a light or radiation wave, etc., as will be discussed below in more detail. - Additionally, in some aspects, scaffold material 36 (or 37) and
adhesive component 34 may be formed from substantially the same material. Alternatively or in addition, in some aspects where both are bioresorbable, scaffold material 36 (or 37) andadhesive component 34 may be formed from materials having substantially the same rate of resorption, which may provide a therapeutic benefit with respect to uniform degradation of the fixated structure, avoiding inflammation, or providing improved healing. - Referring to
FIG. 2 , the method may optionally include adding additional therapeutic or structural materials, or both, to the structure (Block 29). For example, bone growth-promoting materials may be added to promote bone fusion. Further, for example, void fillers such as bone cement or bone-growth scaffold may be added to fill gaps between the bones. Additionally, other therapeutic agents such as gene therapy agents, infection-avoidance agents, pain-relieving agents, etc., may be added. - As discussed above, and referring again to
FIGS. 2 , 4 and 7, once the bone segments and scaffold material are positioned as desired and contacted with the adhesive component, the bones and scaffold material are fixated relative to one another to form a composite bone structure (Block 31). In one aspect, for example, fixatingbones 30 and 32 (or 30, 32 and 33) is based on changing at leastadhesive component 34 from a first material state to a second material state. At the first material state,adhesive component 34 may comprise a relatively flexible state. For example, in some aspects, the first material state may be a liquid state, a semi-solid state, or a non-rigid solid state. In some aspects, for example, the first material state has a viscosity sufficient to enableadhesive component 34 to be controllably positioned. For example,adhesive component 34 may be controllably positioned by having a viscosity and adhesion characteristic that allowsadhesive component 34 to be controllably maintained on a desired surface, such as on a respective bone surface or on scaffold material, or both, to allow a user to avoid contacting the adhesive component with non-desired contact areas, such as areas within a surgical site other than the prepared surfaces of the bones or other than within scaffold material, or both. In any case, at the first material state,adhesive component 34 comprises sufficient flexibility to enable contact with bones and scaffold material. At the second material state,adhesive component 34 is operable to bind toscaffold material 36 as well as to two ormore bones 30 and 32 (or 30, 32 and 33). Further, at the second material state,adhesive component 34 forms a structure having a desired rigidity or stiffness. The desired rigidity or stiffness may include, but is not limited to, a range of rigidities or stiffnesses substantially corresponding to the range of rigidities of hard tissue, such as the particular hard tissue comprising one or more ofbones 30 and 32 (or 30, 32 and 33). In any case, at the second material state,adhesive component 34 comprises sufficient rigidity or stiffness to resist movement of the bones and scaffold material from the desired shape or orientation. For example, the amount of such resistance may be based on typical skeletal loads at the given defect location, or on the typical strength of bones in the defect location, or both. Thus, referring toFIGS. 4 , 5 and 7,adhesive component 34, which may be carried by scaffoldingmaterial more bones 30 and 32 (or 30, 32 and 33) at a desired orientation, thereby forming a composite bone structure 70 (FIG. 5 ) or 71 (FIG. 7 ) having a desired shape or form to treat or remodelhard tissue defect 10 or 12 (FIG. 1 ) or 11 (FIG. 7 ). - Optionally, in some aspects, the fixating may further include changing the state of scaffold material 36 (or 37) from a first state having substantial flexibility to a second state having substantial rigidity or stiffness. For example, the substantial flexibility comprises an amount of flexibility that allows
scaffold material more bones 30 and 32 (or 30, 32 and 33). Further, for example, the substantial rigidity may include an amount of rigidity or stiffness at the second state greater than the amount that existed at the first state, which may include an amount of rigidity or stiffness to resist movement of the bones and the scaffold material out of the desired shape or form. - In particular, referring specifically to
FIG. 4 , in aspects in whichadhesive component 34, and optionally scaffold material 36 (or 37), comprises a polymer, the changing of states ofadhesive component 34 involves application of aninitiator 69 operable to change at leastadhesive component 34 to a second polymer state different from a first polymer state, wherein the second polymer state comprises a cured state or a partially-cured or partial polymerization state. For example, depending on the specific procedure, it may be desirable to fully cureadhesive component 34 at one time, hence fully setting the form and structure of the resulting composite bone structure 70 (or 71;FIG. 7 ). In other aspects, for example, it may be desirable to only partially cureadhesive component 34, allowing for later manipulation of the form or structure ofcomposite bone structure composite bone structure composite bone structure - As noted above, the state changes may be effected by
initiator 69.Initiator 69 may include, but is not limited to, a radiation-based initiator, of which a light based initiator would be one example, a temperature change-based initiator, a chemical-based initiator, or any combination thereof or any combination of different types of each one. For example,adhesive component 34 may comprise a multi-part adhesive having at least two parts, wherein combination of a second part with the first part initiates a chemical reaction operable to changeadhesive component 34 from the first relatively flexible state to the second relatively rigid state. One example of such amulti-part adhesive component 34 includes, but is not limited to, a biodegradable, polyester urethane/urea composition such as one of the NOVOSORB materials available from PolyNovo Biomaterials Pty. Ltd. of Australia. In another example, the radiation-based, or more specifically the light-based, initiator may comprise exposure to one or more light waves or radiation waves having a desired wavelength or range/band or ranges/bands of desired wavelengths to effect curing of the adhesive component. For instance, withadhesive component 34 comprising a urethane-based polymer, theinitiator 69 may comprise ambient light, which includes as a component light of the wavelength of interest and which may slowly cure the adhesive component. However, a light of greater intensity and, specifically, with a greater intensity at a specific wavelength or band of wavelengths may be used to accelerate the light based curing process. - As noted above, the application of
initiator 69 may differ throughout the fixation process, such as in the case where a partial fixation is achieved prior to a final fixation. For example, in the case ofadhesive component 34 comprising a polymer, the method of causing polymerization up to a partial polymerization state may further include exposingadhesive component 34 to a first radiation at a first set of one or more wavelengths for a first time period operable to achieve less than substantially all of the mechanical strength of adhesive component. In this aspect, in one example, the first radiation has a source including a laser or other directed source that generates locally-focused radiation waves directed substantially onadhesive material 34. In this case, in one optional aspect, changingadhesive component 34 to the substantially fully polymerized state may include additionally exposingadhesive component 34 to the first radiation for a second time period. In a different optional aspect, changing the adhesive component to the substantially fully polymerized state may include additionally exposing the adhesive component to a second radiation for a second time period and/or at a second set of one or more wavelengths different from the first set of one or more wavelengths. For example, the second radiation may have a source including a different type of laser or other directed light source, or may include an ambient radiation source operable to generate non-locally-focused light waves, i.e. radiation or light waves not directed primarily on the adhesive component or the scaffold material. - Optionally, in some aspects, adhesive component 34 (and/or
scaffold material 36 or 37) may have a different perceived color at each material state. Thus, by changing from one perceived color to another, which includes a shift in wavelength (for example, from red to blue) or a shift in intensity (for example, from light blue to dark blue),adhesive component 34 may provide a perceptible visual indicator corresponding to the respective material state, thereby aiding a surgeon or other party in ascertaining the material state. - As noted above, although
composite bone structure bones composite bone structures composite bone structure hard tissue defect more bones - For example, the method of joining composite bone structure to another bone may include positioning the composite bone structure adjacent to at least one other bone at the implant site. Further, the method may include positioning a second scaffold material including a second adhesive component across at least a portion of each of the composite bone structure and the at least one other bone such that the second adhesive component is in contact with both the composite bone structure and the at least one other bone. When performing the conforming and the contacting, the second scaffold material and the second adhesive component both comprise a material state being substantially flexible. Finally, this method includes fixating the composite bone structure and the at least one other bone based on changing at least the second adhesive component to another material state at which the second adhesive component chemically or mechanically binds to the second scaffold material, the composite bone structure and the at least one other bone, thereby forming a structure having a desired rigidity, as described above.
- Additionally, it should be noted that although
FIGS. 4 and 5 includebone segments periosteum 50, one or both ofbone segments periosteum 50, such as in the case of one or bothsegments - In another example, in some aspects, the method of
FIG. 2 may be utilized specifically for craniomaxillofacial surgery. In this case, for example, the method of craniomaxillofacial surgery includes accessing at least two bones at least partially defining a hard tissue defect at a location within a body, wherein the location comprises a cranial location or a maxillofacial location or mandible. In this case, at least one of the bones may be obtained from the defect location, while one or more of the other bones may be obtained from another harvesting location on the body, or may be obtained as an allograft. In other cases, such as when a reconstruction is desired using the existing hard tissue, the bones may be obtained from the hard tissue location. Further, it should be noted that at least one of the bones may be a portion of cranial or maxillofacial bone at or adjacent to the hard tissue defect location and connected to or integral with the skull. Additionally, in this specific example, the hard tissue defect location comprises one of a cranial location or a maxillofacial location. - Further, the method of craniomaxillofacial surgery includes positioning the bones into a desired relative orientation. Generally, the bones are positioned such that opposing surfaces of the respective bone segments are facing one another, thereby defining an interface between the bone segments.
- Additionally, the method of craniomaxillofacial surgery includes conforming a scaffold material to at least a portion of a surface of each of the bones. Further, the method includes contacting an adhesive component between at least a portion of each of the bones and the scaffold material. In this case, for example, the scaffold material spans the interface between the bones, thereby allowing the adhesive component to define a connection between the bones and the scaffold material. Additionally, to enable achieving a desired contact between the scaffold material and adhesive component and the bones, the scaffold material and the adhesive component both comprise a first material state being substantially flexible to allow such contact.
- Additionally, the method of craniomaxillofacial surgery includes fixating the bones and the scaffold material in the desired relative orientation to remodel the hard tissue defect. In this case, the fixating is based on changing at least the adhesive component to a second material state at which the adhesive component mechanically or chemically binds the bones and the scaffold material, thereby forming a composite bone structure having a desired rigidity. In an optional aspect, the fixating may involve both the adhesive component and the scaffold material changing into the second material state to define the relatively rigid structure used to repair the hard tissue defect.
- Thus, referring again to
FIGS. 3-5 and 7, the above-described methods allow for the formation of a composite bone structure 70 (FIG. 5 ) or 71 (FIG. 7 ) that includes hard tissues/bones adhesive component 34 carried by ascaffold material FIGS. 3-5 , hard tissue/bone 30 has afirst surface 52 and hard tissue/bone 32 has asecond surface 54, andbones interface 68 between at least a portion of therespective surfaces scaffold material 36 is positioned adjacent to at least a portion of the hard tissues/bones scaffold material 36 spans at least a portion ofinterface 68. Further,adhesive component 34 is in contact with at least a portion of each of the hard tissues/bones scaffold material 36.Scaffold material 36 andadhesive component 34 both initially comprise a first material state being substantially flexible to enable their positioning relative to the respective hard tissues/bones adhesive component 34 is changeable to a second material state at whichadhesive component 34 binds to each of the hard tissues/bones scaffold material 36, thereby definingcomposite bone structure 70 having a desired rigidity. Similarly, with respect toFIG. 7 ,scaffold material 37 wraps around hard tissues/bones adhesive component 34 affixes the hard tissues/bones scaffold material 37 in a desired orientation and further definescomposite bone structure 71 having a desired rigidity. - While the foregoing disclosure discusses illustrative aspects and/or embodiments, it should be noted that various changes and modifications could be made herein without departing from the scope of the invention as defined by the appended claims. Furthermore, although elements of the described aspects and/or embodiments may be described or claimed in the singular, the plural is contemplated unless limitation to the singular is explicitly stated. Additionally, all or a portion of any aspect and/or embodiment may be utilized with all or a portion of any other aspect and/or embodiment, unless stated otherwise.
Claims (35)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/101,571 US20090259263A1 (en) | 2008-04-11 | 2008-04-11 | Apparatus and methods of fixating bone |
EP09729417A EP2276421A1 (en) | 2008-04-11 | 2009-04-09 | Apparatus and methods of fixating bone |
PCT/US2009/040094 WO2009126820A1 (en) | 2008-04-11 | 2009-04-09 | Apparatus and methods of fixating bone |
US13/458,401 US9277997B2 (en) | 2008-04-11 | 2012-04-27 | Apparatus and methods of fixating bone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/101,571 US20090259263A1 (en) | 2008-04-11 | 2008-04-11 | Apparatus and methods of fixating bone |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/458,401 Division US9277997B2 (en) | 2008-04-11 | 2012-04-27 | Apparatus and methods of fixating bone |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090259263A1 true US20090259263A1 (en) | 2009-10-15 |
Family
ID=41059789
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/101,571 Abandoned US20090259263A1 (en) | 2008-04-11 | 2008-04-11 | Apparatus and methods of fixating bone |
US13/458,401 Expired - Fee Related US9277997B2 (en) | 2008-04-11 | 2012-04-27 | Apparatus and methods of fixating bone |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/458,401 Expired - Fee Related US9277997B2 (en) | 2008-04-11 | 2012-04-27 | Apparatus and methods of fixating bone |
Country Status (3)
Country | Link |
---|---|
US (2) | US20090259263A1 (en) |
EP (1) | EP2276421A1 (en) |
WO (1) | WO2009126820A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120215322A1 (en) * | 2008-12-30 | 2012-08-23 | Industrial Technology Research Institute | Artificial dura biomedical device and brain surgery method utilizing the same |
US20120265313A1 (en) * | 2011-04-01 | 2012-10-18 | Shawn Burke | Method of Cranial Repair and Cranial Repair Implant Molding Device |
US20160331539A1 (en) * | 2015-05-12 | 2016-11-17 | Elwha Llc | Modifiable implants |
WO2018022138A1 (en) * | 2016-07-26 | 2018-02-01 | Osty Meditech, LLC | Implants and methods for cosmetic surgery |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9968455B2 (en) | 2012-04-27 | 2018-05-15 | Howmedica Osteonics Corp. | Multiple component bone void filling implant |
GB2544266A (en) * | 2015-11-03 | 2017-05-17 | Attenborough Dental Laboratories Ltd | Implant |
CN110811933B (en) * | 2019-12-12 | 2021-09-03 | 安徽中健三维科技有限公司 | Titanium alloy bone defect support based on 3D printing technology |
Citations (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3849805A (en) * | 1972-11-01 | 1974-11-26 | Attending Staff Ass Los Angele | Bone induction in an alloplastic tray |
US4329743A (en) * | 1979-04-27 | 1982-05-18 | College Of Medicine And Dentistry Of New Jersey | Bio-absorbable composite tissue scaffold |
US4512038A (en) * | 1979-04-27 | 1985-04-23 | University Of Medicine And Dentistry Of New Jersey | Bio-absorbable composite tissue scaffold |
US4636215A (en) * | 1984-01-11 | 1987-01-13 | Rei, Inc. | Combination tray and condylar prosthesis for mandibular reconstruction and the like |
US4678436A (en) * | 1985-05-27 | 1987-07-07 | G-C Dental Industrial Corp. | Color-changeable cement composition for dental use |
US4966599A (en) * | 1987-04-07 | 1990-10-30 | Pollock Richard A | Anatomical precontoured plating, instruments and methods |
US5306304A (en) * | 1990-10-31 | 1994-04-26 | El Gendler | Flexible membranes produced from organic bone matrix for skeletal repair and reconstruction |
US5397361A (en) * | 1993-06-23 | 1995-03-14 | Surgical Prosthetics Resource, Inc. | Cranioplasty surgical procedure and kit |
US5461124A (en) * | 1992-07-24 | 1995-10-24 | Henkel Kommanditgesellschaft Auf Aktien | Reactive systems and/or polymer composition for tissue contact with the living body |
US5468242A (en) * | 1993-11-19 | 1995-11-21 | Leibinger Gmbh | Form-fitting mesh implant |
US5496371A (en) * | 1991-06-10 | 1996-03-05 | United States Surgical Corporation | Prosthetic implant |
US5503164A (en) * | 1994-01-28 | 1996-04-02 | Osteogenics, Inc. | Device and method for repair of craniomaxillofacial bone defects including burr holes |
US5549678A (en) * | 1991-10-25 | 1996-08-27 | Prostkoff; Melvin E. | Cranial prosthesis |
US5569250A (en) * | 1994-03-01 | 1996-10-29 | Sarver; David R. | Method and apparatus for securing adjacent bone portions |
US5660225A (en) * | 1993-08-30 | 1997-08-26 | Saffran; Bruce Nathan | Method of fracture treatment by restraining macromolecules or macromolecular aggregates adjacent to damaged tissues |
US5690631A (en) * | 1996-09-11 | 1997-11-25 | Walter Lorenz Surgical, Inc. | Multi-configurable plating system |
US5766176A (en) * | 1996-09-11 | 1998-06-16 | Walter Lorenz Surgical, Inc. | Formable mesh |
US5773418A (en) * | 1992-10-08 | 1998-06-30 | Bristol-Myers Squibb Company | Fibrin sealant compositions and methods for utilizing same |
US5839899A (en) * | 1996-03-01 | 1998-11-24 | Robinson; Dane Q. | Method and apparatus for growing jaw bone utilizing a guided-tissue regeneration plate support and fixation system |
US5876447A (en) * | 1996-02-14 | 1999-03-02 | Implantech Associates | Silicone implant for facial plastic surgery |
US5919234A (en) * | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6071291A (en) * | 1997-10-21 | 2000-06-06 | Howmedica Leibinger Gmbh & Co. Kg (Leibinger) | Micro dynamic mesh |
US6117425A (en) * | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
US6206883B1 (en) * | 1999-03-05 | 2001-03-27 | Stryker Technologies Corporation | Bioabsorbable materials and medical devices made therefrom |
US6221075B1 (en) * | 1998-03-06 | 2001-04-24 | Bionx Implants Oy | Bioabsorbable, deformable fixation plate |
US6228117B1 (en) * | 1997-07-16 | 2001-05-08 | Isotis B.V. | Device for tissue engineering bone |
US6280473B1 (en) * | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6313819B1 (en) * | 1997-08-29 | 2001-11-06 | Sony Corporation | Liquid crystal display device |
US6325803B1 (en) * | 1998-02-18 | 2001-12-04 | Walter Lorenz Surgical, Inc. | Method and apparatus for mandibular osteosynthesis |
US6328765B1 (en) * | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
US6391049B1 (en) * | 1999-10-06 | 2002-05-21 | Board Of Regents The University Of Texas System | Solid biodegradable device for use in tissue repair |
US6391059B1 (en) * | 1998-04-07 | 2002-05-21 | Macropore, Inc. | Membrane with tissue-guiding surface corrugations |
US6485503B2 (en) * | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
US6511511B1 (en) * | 1997-05-30 | 2003-01-28 | Osteobiologics, Inc. | Fiber-reinforced, porous, biodegradable implant device |
US6645226B1 (en) * | 2000-05-19 | 2003-11-11 | Coapt Systems, Inc. | Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing |
US6656489B1 (en) * | 1999-02-10 | 2003-12-02 | Isotis N.V. | Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material |
US6685707B2 (en) * | 2001-09-25 | 2004-02-03 | Walter Lorenz Surgical, Inc. | Cranial clamp and method for fixating a bone plate |
US6692498B1 (en) * | 2000-11-27 | 2004-02-17 | Linvatec Corporation | Bioabsorbable, osteopromoting fixation plate |
US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6712851B1 (en) * | 1998-01-23 | 2004-03-30 | Macropore Biosurgery, Inc. | Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6731252B2 (en) * | 2001-02-09 | 2004-05-04 | Yazaki Corporation | Display source unit for display device in vehicle |
US20040236371A1 (en) * | 2003-01-24 | 2004-11-25 | Mcnally-Heintzelman Karen M. | Light-activated adhesive composite, system, and methods of use thereof |
US6827743B2 (en) * | 2001-02-28 | 2004-12-07 | Sdgi Holdings, Inc. | Woven orthopedic implants |
US20050004599A1 (en) * | 2003-06-30 | 2005-01-06 | Mcnally-Heintzelman Karen M. | Non-light activated adhesive composite, system, and methods of use thereof |
USRE39321E1 (en) * | 1990-11-27 | 2006-10-03 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US20070260325A1 (en) * | 2006-05-02 | 2007-11-08 | Robert Wenz | Bone cement compositions comprising an indicator agent and related methods thereof |
US20070270974A1 (en) * | 2001-03-02 | 2007-11-22 | Woodwelding Ag | Implants for creating connections to tissue parts, in particular to skeletal parts, as well as device and method for implantation thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2724814C3 (en) * | 1977-06-02 | 1980-03-27 | Kulzer & Co Gmbh, 6380 Bad Homburg | Preliminary product for the preparation of bone cement |
US5556429A (en) * | 1994-05-06 | 1996-09-17 | Advanced Bio Surfaces, Inc. | Joint resurfacing system |
US6299905B1 (en) * | 1996-04-16 | 2001-10-09 | Depuy Orthopaedics, Inc. | Bioerodable polymeric adhesives for tissue repair |
US6336930B1 (en) * | 2000-03-07 | 2002-01-08 | Zimmer, Inc. | Polymer filled bone plate |
JP2001327520A (en) * | 2000-05-23 | 2001-11-27 | Takiron Co Ltd | In vivo decomposition absorptive tacky adhesive tape for medical purpose |
JP2004512099A (en) * | 2000-10-25 | 2004-04-22 | エスディージーアイ・ホールディングス・インコーポレーテッド | Self-conforming orthopedic implant |
US6605090B1 (en) * | 2000-10-25 | 2003-08-12 | Sdgi Holdings, Inc. | Non-metallic implant devices and intra-operative methods for assembly and fixation |
US6632235B2 (en) * | 2001-04-19 | 2003-10-14 | Synthes (U.S.A.) | Inflatable device and method for reducing fractures in bone and in treating the spine |
WO2007079053A2 (en) * | 2005-12-28 | 2007-07-12 | Dentsply International Inc. | Light-curable bone growth material for treating dental bone defects |
US8870871B2 (en) * | 2007-01-17 | 2014-10-28 | University Of Massachusetts Lowell | Biodegradable bone plates and bonding systems |
KR20100036275A (en) * | 2007-06-29 | 2010-04-07 | 신세스 게엠바하 | Improved orthopedic implants for use with precision bone resurfacing instrumentation |
-
2008
- 2008-04-11 US US12/101,571 patent/US20090259263A1/en not_active Abandoned
-
2009
- 2009-04-09 EP EP09729417A patent/EP2276421A1/en not_active Withdrawn
- 2009-04-09 WO PCT/US2009/040094 patent/WO2009126820A1/en active Application Filing
-
2012
- 2012-04-27 US US13/458,401 patent/US9277997B2/en not_active Expired - Fee Related
Patent Citations (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3849805A (en) * | 1972-11-01 | 1974-11-26 | Attending Staff Ass Los Angele | Bone induction in an alloplastic tray |
US4329743A (en) * | 1979-04-27 | 1982-05-18 | College Of Medicine And Dentistry Of New Jersey | Bio-absorbable composite tissue scaffold |
US4512038A (en) * | 1979-04-27 | 1985-04-23 | University Of Medicine And Dentistry Of New Jersey | Bio-absorbable composite tissue scaffold |
US4636215A (en) * | 1984-01-11 | 1987-01-13 | Rei, Inc. | Combination tray and condylar prosthesis for mandibular reconstruction and the like |
US4678436A (en) * | 1985-05-27 | 1987-07-07 | G-C Dental Industrial Corp. | Color-changeable cement composition for dental use |
US5413577A (en) * | 1987-04-07 | 1995-05-09 | Pollock; Richard A. | Anatomical precontoured plating |
US4966599A (en) * | 1987-04-07 | 1990-10-30 | Pollock Richard A | Anatomical precontoured plating, instruments and methods |
US5306304A (en) * | 1990-10-31 | 1994-04-26 | El Gendler | Flexible membranes produced from organic bone matrix for skeletal repair and reconstruction |
US6117425A (en) * | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
USRE39321E1 (en) * | 1990-11-27 | 2006-10-03 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US5496371A (en) * | 1991-06-10 | 1996-03-05 | United States Surgical Corporation | Prosthetic implant |
US5549678A (en) * | 1991-10-25 | 1996-08-27 | Prostkoff; Melvin E. | Cranial prosthesis |
US5461124A (en) * | 1992-07-24 | 1995-10-24 | Henkel Kommanditgesellschaft Auf Aktien | Reactive systems and/or polymer composition for tissue contact with the living body |
US5773418A (en) * | 1992-10-08 | 1998-06-30 | Bristol-Myers Squibb Company | Fibrin sealant compositions and methods for utilizing same |
US5397361A (en) * | 1993-06-23 | 1995-03-14 | Surgical Prosthetics Resource, Inc. | Cranioplasty surgical procedure and kit |
US5660225A (en) * | 1993-08-30 | 1997-08-26 | Saffran; Bruce Nathan | Method of fracture treatment by restraining macromolecules or macromolecular aggregates adjacent to damaged tissues |
US5468242A (en) * | 1993-11-19 | 1995-11-21 | Leibinger Gmbh | Form-fitting mesh implant |
US5503164A (en) * | 1994-01-28 | 1996-04-02 | Osteogenics, Inc. | Device and method for repair of craniomaxillofacial bone defects including burr holes |
US5868746A (en) * | 1994-03-01 | 1999-02-09 | Biomet, Inc. | Method and apparatus for securing adjacent bone portions |
US5569250A (en) * | 1994-03-01 | 1996-10-29 | Sarver; David R. | Method and apparatus for securing adjacent bone portions |
US5876447A (en) * | 1996-02-14 | 1999-03-02 | Implantech Associates | Silicone implant for facial plastic surgery |
US6394807B2 (en) * | 1996-03-01 | 2002-05-28 | Dane O. Robinson | Guided tissue regeneration plate for use in a process for growing jaw bone in anticipation of performing dental implants |
US5839899A (en) * | 1996-03-01 | 1998-11-24 | Robinson; Dane Q. | Method and apparatus for growing jaw bone utilizing a guided-tissue regeneration plate support and fixation system |
US6238214B1 (en) * | 1996-03-01 | 2001-05-29 | Dane Q. Robinson | Guided tissue regeneration plate for use in a process for growing jaw bone in anticipation of performing dental implants |
US6280473B1 (en) * | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US5919234A (en) * | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US5766176A (en) * | 1996-09-11 | 1998-06-16 | Walter Lorenz Surgical, Inc. | Formable mesh |
US5690631A (en) * | 1996-09-11 | 1997-11-25 | Walter Lorenz Surgical, Inc. | Multi-configurable plating system |
US6511511B1 (en) * | 1997-05-30 | 2003-01-28 | Osteobiologics, Inc. | Fiber-reinforced, porous, biodegradable implant device |
US6228117B1 (en) * | 1997-07-16 | 2001-05-08 | Isotis B.V. | Device for tissue engineering bone |
US6313819B1 (en) * | 1997-08-29 | 2001-11-06 | Sony Corporation | Liquid crystal display device |
US6071291A (en) * | 1997-10-21 | 2000-06-06 | Howmedica Leibinger Gmbh & Co. Kg (Leibinger) | Micro dynamic mesh |
US6712851B1 (en) * | 1998-01-23 | 2004-03-30 | Macropore Biosurgery, Inc. | Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6325803B1 (en) * | 1998-02-18 | 2001-12-04 | Walter Lorenz Surgical, Inc. | Method and apparatus for mandibular osteosynthesis |
US6221075B1 (en) * | 1998-03-06 | 2001-04-24 | Bionx Implants Oy | Bioabsorbable, deformable fixation plate |
US6692497B1 (en) * | 1998-03-06 | 2004-02-17 | Toermaelae Pertti | Bioabsorbable, deformable fixation plate |
US6391059B1 (en) * | 1998-04-07 | 2002-05-21 | Macropore, Inc. | Membrane with tissue-guiding surface corrugations |
US6328765B1 (en) * | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
US6656489B1 (en) * | 1999-02-10 | 2003-12-02 | Isotis N.V. | Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material |
US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6716957B2 (en) * | 1999-03-05 | 2004-04-06 | Stryker Technologies Corporation | Bioabsorbable materials and medical devices made therefrom |
US6206883B1 (en) * | 1999-03-05 | 2001-03-27 | Stryker Technologies Corporation | Bioabsorbable materials and medical devices made therefrom |
US6391049B1 (en) * | 1999-10-06 | 2002-05-21 | Board Of Regents The University Of Texas System | Solid biodegradable device for use in tissue repair |
US6893452B2 (en) * | 2000-05-19 | 2005-05-17 | Coapt Systems, Inc. | Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing |
US6645226B1 (en) * | 2000-05-19 | 2003-11-11 | Coapt Systems, Inc. | Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing |
US6485503B2 (en) * | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
US6692498B1 (en) * | 2000-11-27 | 2004-02-17 | Linvatec Corporation | Bioabsorbable, osteopromoting fixation plate |
US6731252B2 (en) * | 2001-02-09 | 2004-05-04 | Yazaki Corporation | Display source unit for display device in vehicle |
US6827743B2 (en) * | 2001-02-28 | 2004-12-07 | Sdgi Holdings, Inc. | Woven orthopedic implants |
US20070270974A1 (en) * | 2001-03-02 | 2007-11-22 | Woodwelding Ag | Implants for creating connections to tissue parts, in particular to skeletal parts, as well as device and method for implantation thereof |
US6685707B2 (en) * | 2001-09-25 | 2004-02-03 | Walter Lorenz Surgical, Inc. | Cranial clamp and method for fixating a bone plate |
US20040236371A1 (en) * | 2003-01-24 | 2004-11-25 | Mcnally-Heintzelman Karen M. | Light-activated adhesive composite, system, and methods of use thereof |
US20050004599A1 (en) * | 2003-06-30 | 2005-01-06 | Mcnally-Heintzelman Karen M. | Non-light activated adhesive composite, system, and methods of use thereof |
US20070260325A1 (en) * | 2006-05-02 | 2007-11-08 | Robert Wenz | Bone cement compositions comprising an indicator agent and related methods thereof |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120215322A1 (en) * | 2008-12-30 | 2012-08-23 | Industrial Technology Research Institute | Artificial dura biomedical device and brain surgery method utilizing the same |
US8986394B2 (en) * | 2008-12-30 | 2015-03-24 | Industrial Technology Research Institute | Artificial dura biomedical device and brain surgery method utilizing the same |
US20120265313A1 (en) * | 2011-04-01 | 2012-10-18 | Shawn Burke | Method of Cranial Repair and Cranial Repair Implant Molding Device |
US8673014B2 (en) * | 2011-04-01 | 2014-03-18 | Kls-Martin, L.P. | Method of cranial repair and cranial repair implant molding device |
US20160331539A1 (en) * | 2015-05-12 | 2016-11-17 | Elwha Llc | Modifiable implants |
WO2018022138A1 (en) * | 2016-07-26 | 2018-02-01 | Osty Meditech, LLC | Implants and methods for cosmetic surgery |
US10772728B2 (en) | 2016-07-26 | 2020-09-15 | Yougun Kim | Implants and methods for cosmetic surgery |
Also Published As
Publication number | Publication date |
---|---|
US9277997B2 (en) | 2016-03-08 |
US20120226327A1 (en) | 2012-09-06 |
EP2276421A1 (en) | 2011-01-26 |
WO2009126820A1 (en) | 2009-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9277997B2 (en) | Apparatus and methods of fixating bone | |
US9585755B2 (en) | Fracture fixation systems having intramedullary support | |
EP0928168B1 (en) | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration | |
RU2355352C2 (en) | Bone tissue or bone substitute filled bone tissue implant | |
JP2011528960A (en) | Fracture fixation system | |
US20120277807A1 (en) | Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone | |
JP2005507681A (en) | Form-compatible bioabsorbable mesh implant | |
WO2007142743A2 (en) | Craniofacial implant | |
JP2009131611A (en) | Remodelable orthopaedic spacer and method of using the same | |
US20040153075A1 (en) | Surgical fixation device | |
CN104546103A (en) | Absorbable intraosseous fixing device with biological activity and plasticity and forming method | |
US10105229B2 (en) | Methods for bone and cartilage reconstruction | |
US9039784B2 (en) | Micro-structure particles for load bearing bone growth | |
JP7389531B2 (en) | Non-fixed implant for craniotomy and its manufacturing method | |
Schultz | Reconstruction of facial deformities with alloplastic material | |
FI20195638A1 (en) | Fiber-reinforced composite device for the management and treatment of musculoskeletal and dental disorders with functionalized spatial arrangement of continuous fibers | |
KR20120101442A (en) | Distraction tool for bone growth | |
Schultz | Restoration of frontal contour with methyl methacrylate | |
US11839549B2 (en) | Materials in orthopedics and fracture fixation | |
TW202130374A (en) | Method for manufacturing multi-microporous bone scaffold | |
EP2415413A1 (en) | Device for enhancement of bone fixation | |
Ali et al. | Recent advances in reconstructive oral and maxillofacial surgery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BIOMET MICROFIXATION, LLC, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STEGER, SHON DAVID;MCKEE, ROBERT TRAVIS;ROMAN, SHAWN DAVID;AND OTHERS;REEL/FRAME:022938/0225;SIGNING DATES FROM 20080403 TO 20080408 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC;AND OTHERS;REEL/FRAME:023505/0241 Effective date: 20091111 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: BIOMET TRAVEL, INC., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET INTERNATIONAL LTD., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET SPORTS MEDICINE, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET 3I, LLC, FLORIDA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET MANUFACTURING CORPORATION, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: KIRSCHNER MEDICAL CORPORATION, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET EUROPE LTD., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: IMPLANT INNOVATIONS HOLDINGS, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET HOLDINGS LTD., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: INTERPORE SPINE, LTD., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: EBI HOLDINGS, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET FLORIDA SERVICES, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET FAIR LAWN LLC, NEW JERSEY Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOLECTRON, INC., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: LVB ACQUISITION, INC., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET, INC., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: ELECTR-OBIOLOGY, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET BIOLOGICS, LLC., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: CROSS MEDICAL PRODUCTS, LLC, CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: EBI MEDICAL SYSTEMS, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET MICROFIXATION, LLC, FLORIDA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: EBI, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET LEASING, INC., INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: INTERPORE CROSS INTERNATIONAL, LLC, CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 Owner name: BIOMET ORTHOPEDICS, LLC, INDIANA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:037155/0082 Effective date: 20150624 |